text: CASI Pharmaceuticals | EntreMed to Present at Needham Biotechnology Conference
  EntreMed to Present at Needham Biotechnology Conference
  ROCKVILLE, MD, May 19—EntreMed, Inc. (Nasdaq: ENMD) a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today announced that James S. Burns, President and Chief Executive Officer, will present a Corporate overview at the Fourth Annual Needham Biotechnology Conference, to be held at the New York Palace Hotel, May 25-26, 2005. Mr. Burns' presentation is scheduled for Thursday, May 26, 2005 at 1:00 p.m. (local time).